文章摘要
儿童难治性癫痫外周血microRNAs的表达研究
Expression of microRNAs in peripheral blood of children with refractory epilepsy
投稿时间:2023-06-08  修订日期:2023-06-08
DOI:
中文关键词: 难治性癫痫  儿童  外周血  miRNAs  发病机制
英文关键词: Refractory epilepsy  Children  Peripheral blood  MiRNAs  Pathogenesis
基金项目:
作者单位邮编
王慧杰 徐州医科大学附属徐州儿童医院 221006
刘晓鸣 徐州医科大学附属徐州儿童医院 221006
陈娇 徐州医科大学附属徐州儿童医院 
摘要点击次数: 364
全文下载次数: 0
中文摘要:
      目的:通过研究儿童难治性癫痫外周血中microRNAs(miRNAs )的差异表达,探索miRNAs在儿童难治性癫痫发病机制中作用及诊疗价值。方法:收集2021年5月-2022年5月在徐州医科大学附属徐州儿童医院神经内科就诊的癫痫患儿46例,分为难治性癫痫组(R组)20例、癫痫控制良好组(C组)26例,另选取同期儿童保健科健康体检儿童为健康对照组(N组)26例,运用高通量测序技术检测三组儿童外周全血中miRNAs的表达,DEseq2软件筛选差异表达的miRNAs;同样条件R组、C组、N组重新各纳入30例儿童,采集外周血本,运用荧光定量聚合酶链反应(qRT-PCR)扩增技术验证目标miRNA在儿童外周血中的表达水平,miRanda、RNAhybrid在线数据库预测差异表达miRNAs的靶基因并对候选靶基因进行基因功能(GO)分析和基因组百科全书(KEGG)通路分析。结果:与N组相比,R组共有124个差异表达miRNAs,其中74个miRNAs上调,50个miRNAs下调,C组共有66个差异表达miRNAs,其中21个miRNAs上调,45个miRNAs下调;与C组相比,R组共有337个差异表达的miRNAs,其中197个miRNAs上调,140个miRNAs下调,其中差异性最明显的是miR-15a-5p(P=9.00*10-8, |log2(foldchange)|=2.93),对miR-15a-5p进行qRT-PCR扩增,发现其在三组儿童外周血中的表达差异有统计学意义(P<0.001)且与高通量测序结果一致,受试者工作特征曲线(ROC)显示miR-15a-5p在诊断儿童难治性癫痫中具有良好的曲线下面积(AUC)值(0.884)、敏感度(90%)及特异度(83.3%),有望成为儿童难治性癫痫的新型诊断生物标志物。对差异miRNAs进行靶基因预测,并对候选靶基因进行GO分析和KEGG分析,显示miR-15a-5p可能参与调控儿童RE的信号通路包括MAPK信号通路、cAMP信号通路、铂类耐药信号通路、p53信号通路、Ras信号通路、Fc-γ-R介导的吞噬作用信号通路、神经变性疾病信号通路。结论:难治性癫痫儿童外周血中miRNAs的表达谱与癫痫控制良好患儿及健康儿童存在明显差异,其中miR-15a-5p差异性表达最显著,并可能通过调控多条通路参与癫痫的病理生理过程,有望成为儿童难治性癫痫的新型诊断生物标志物及潜在治疗靶点。
英文摘要:
      Objective: To study the differential expression of microRNAs(miRNAs) in peripheral blood of children with refractory epilepsy and to explore the role of miRNAs in the pathogenesis and the value of diagnosis and treatment of refractory epilepsy in children.Methods: Forty-six children with epilepsy treated in the Department of Neurology of XuZhou Children's Hospital affliated to XuZhou Medical University from May 2021 to May 2022 were collected and divided into refractory epilepsy group (group R, n = 20) and wellcontrolled epilepsy group (group C, n = 26). In addition, 26 healthy children in the child health department in the same period were selected as healthy control group (group N).The expression of miRNAs in peripheral blood was determined by high- throughput sequencing.The differentially expressed miRNAs were screened by DEseq2.Peripheral blood samples from 30 children in Group R, Group C, and Group N under the same conditions were collected again, and the expression level of candidate miRNAs in peripheral blood were verified using qRT-PCR amplification technology. The differentially expressed miRNAs target genes were predicted by miRanda and RNAhybrid online database, and the candidate target genes were analyzed by gene function (Gene Ontology,GO) and genomic encyclopedia (Kyoto Encyclopedia of Genes and Genomes,KEGG) pathway. Results: Compared with group N, there were 124 differentially expressed miRNAs in group R, including 74 up-regulated miRNAs and 50 down-regulated miRNAs,and there were 66 differentially expressed miRNAs in group C, including 21 up-regulated miRNAs and 45 down-regulated miRNAs.Compared with group C, there were 337 differentially expressed miRNAs in group R,including 197 up-regulated miRNAs and 140 down-regulated miRNAs.Among them, the most significant difference is miR-15a-5p(P=9.00*10-8, |log2(foldchange)|2=2.93).The target genes of all differential miRNAs were predicted, and the candidate target genes were analyzed by GO and KEGG.Bioinformatics analysis found that the possible signal pathway miR-15a-5p participating in the refractory epilepsy of children included MAPK signal pathway,cAMP signal pathway,platinum drug resistance signal pathway,p53 signal pathway,Ras signal pathway,Fc-γ-R mediated phagocytosis signal pathway and neurodegeneration signal pathway.Conclusions: The expression profile of miRNAs in peripheral blood of refractory epilepsy children is significantly different from that of children with well controlled epilepsy and healthy children, Among them, the most significant difference is miR-15a-5p,and it participates in the pathophysiological process of epilepsy by regulating multiplepathways, which is expected to to become a new diagnostic biomarker and a potential therapeutic target for children with RE.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭